THURSDAY, June 29, 2017 -- Popular hormone-based drugs for treating an enlarged prostate could increase men's risk of type 2 diabetes, heart disease or stroke, a new study suggests.
A group of German men taking the drug Avodart (dutasteride) for three years wound up with higher blood sugar and cholesterol levels than men taking another class of prostate medication that does not affect male hormones, the researchers reported.
THURSDAY, July 13, 2017 -- Men with early stage prostate cancer who have surgery to remove their tumor do not live longer than those who receive no treatment at all, a long-running clinical trial has concluded.
At the same time, nearly one in three men who had the surgery wound up with long-term complications, such as urinary incontinence and erectile dysfunction, said lead researcher Dr. Timothy Wilt. He is a clinical investigator with the Minneapolis Veterans Affairs Health Care System.
THURSDAY, July 13, 2017 -- The larger a man, the greater his risk of getting and dying from aggressive prostate cancer, a new study suggests.
Every additional 4 inches of height increased a man's chances of being diagnosed with high-risk prostate cancer by 21 percent, and their odds of dying from prostate cancer by 17 percent, researchers found.